Correction of compliment system failure in patients with chronic prostatitis

Abstract

The aim of the study was detection of local and systemic changes in the complement system in patients with chronic abacterial prostatitis (CAP) and chronic bacterial prostatitis (CBP) and to assess a relevant corrective efficacy of the hardware and software complex Andro-Gin (KAP-ELM-01 Andro-Gin).
Before treatment, blood plasma of CAP patients contained elevated concentrations of all studied components of the compliment system and factor H but subnormal concentration of C1-inhibitor. Locally, all the compliment indices were high including C1-inhibitor and factor H except component C5. Initial blood plasma compliment fractions in CBP patients were elevated but regulatory proteins concentrations were low. Local compliment components C3, C4, C5 and C5a and factor H were significantly higher. Standard treatment of CAP partially corrected the level of C3, C3a, C4 components, locally normalized concentration of C3 component and corrected C4 component, while in CBP standard treatment normalized concentration of C3 component and reduced C3a, C4, C5 and C5a components, locally normalized the levels of C3, C4 components, corrected concentration of C3a, C5, C5a components, raised regulatory factors. Combination of the standard treatment with Andro-Gin unit compared to standard treatment alone, in CAP corrected plasma concentrations of C3, C3a, C4 compliment components and significantly raised levels of regulatory factors, locally - partially normalized the level of factor H. In CBP additional use of Andro-Gin more significantly improved concentrations of C3a and C5a components , locally - C5a component, raised significantly concentration of regulatory factors C1-inhibitor and factor H. Thus, KAP-ELM-01 Andro-Gin administration in CAP and CBP patients promotes more effective correction of systemic and local disorders in the compliment system, the improvement being more pronounced in CBP.

References

  1. Гориловский Л. М., Зингеренко М. Б. Хронический простатит. Лечащий врач 2003; 7.
  2. Лоран О. Б., Сегал А. С. Хронический простатит. В кн. Материалы X Российского съезда урологов. Москва, 1-3 окт. 2002 г. М.: Информполиграф; 2002. 209-222.
  3. Конопля А. И., Серегин С. П., Шестаков С. Г., Шатохин М. Н. Использование полиоксидония в комплексном лечении хронического простатита. Иммунология 2002; 6: 382-385.
  4. Meares E. M. Prostatitis and related disorders. In: Weidner W. et al. eds. Therapy of prostatitis. München; 1986. 207-212.
  5. Лопаткин Н. А., Пугачев А. Г., Аполихин О. И. Урология. М.: ГЭОТАР-Медиа; 2002.
  6. Караулов А. В. (ред.). Клиническая иммунология и аллергология. М.: МИА; 2002.
  7. Хаитов P. M., Ярилин А. А., Пинегин Б. В. Руководство по клинической иммунологии: иммунодиагностика заболеваний иммунной системы. М.: ГЭОТАР-Медиа; 2009.
  8. Шатохин М. Н., Мальцев В. Н. Влияние лонгидазы на содержание цитокинов при патологии предстательной железы. Аллергол. и иммунол. 2009; 10 (2): 243.
  9. Шестаков С. Г., Конопля А. И. Состояние иммунного статуса и коррекция его нарушений у больных хроническим простатитом. В кн.: Прокопенко Л. Г., Лазарев А. И., Конопля А. И. (ред.). Окислительный, энергетический и иммунный гомеостаз (нарушение и коррекция). Курск: КГМУ; 2003. 253-289.
  10. Дранник Г. Н. Строение и функции иммунной системы. Лекция № 2. Врожденный неспецифический (естественный) иммунитет. Гуморальный иммунитет. Клин. иммунол. Аллергол. Инфектол. 2005; 15-18.
  11. Ярилин А. А. Иммунология: Учебник. М.: ГЭОТАР-Медиа; 2010.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies